SCHEMBL13784141

SCHEMBL13784141

CC(C)n1c(-c2ccc(-c3ccc(-c4nc5ccccc5nc4-c4ccccc4)cc3)cc2)nc2ccccc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.64
ALDH1A1 P00352 6/20 0.64
LMNA P02545 5/20 0.64
HPGD P15428 4/20 0.64
HSD17B10 Q99714 4/20 0.64
TP53 P04637 2/20 0.64
RAB9A P51151 2/20 0.64
MAPT P10636 1/20 0.64
ALPG P10696 1/20 0.64
TDP1 Q9NUW8 2/20 0.53
RPS6KB1 P23443 1/20 0.51
GSK3B P49841 1/20 0.51
ROCK1 Q13464 1/20 0.51
USP2 O75604 1/20 0.47
HTT P42858 1/20 0.47
NCOA1 Q15788 1/20 0.47
NCOA3 Q9Y6Q9 1/20 0.47
HDAC1 Q13547 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2607467 0.89 ALDH1A1 (0.72) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL13784142 0.87 KDM4E (0.50) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL16692136 0.81 ALDH1A1 (0.66) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL27952100 0.81 ALDH1A1 (0.69) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL13784138 0.81 ALDH1A1 (0.65) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL13784140 0.80 HSD17B10 (0.58) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL12387034 0.78 KDM4E (0.66) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL13784143 0.77 TDP1 (0.53) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL13784137 0.77 KDM4E (0.68) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL13784113 0.77 ESR1 (0.64) KDM4EALDH1A1LMNAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815412-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic appliance using the quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-08-26 US disclosed
US-8815412-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic appliance using the quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-08-26 US disclosed
US-20090184633-A1 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Quinoxaline Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-07-23 US disclosed
US-20090184633-A1 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Quinoxaline Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090184633-A1 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Quinoxaline Derivative H1-0, NQO2, GDI1 KDM4E 443/4885ALDH1A1 499/4885LMNA 2700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.